
California, US residents click here
The job details are as follows:
Who We Are
We are the first publicly-traded biotech or pharmaceutical company to take the form of a public benefit corporation. Our public benefit purpose is to provide a brighter future for patients through the development of novel pharmaceutical therapies; and technologies that expand the availability of transplantable organs.
United Therapeutics (Nasdaq: UTHR) seeks to travel down the corridors of indifference to develop treatments for rare, deadly diseases. We were founded in 1996 by a family seeking a cure for their daughter’s pulmonary arterial hypertension ( PAH). Today, we have six FDA-approved therapies that treat PAH, pulmonary hypertension associated with interstitial lung disease ( PH-ILD) and neuroblastoma, a rare pediatric cancer. Our near-term pipeline seeks to develop additional therapies for PAH and pulmonary fibrosis ( PF).
The cure for end-stage life-threatening diseases like PAH, PH-ILD, PF, and many others is an organ transplant, but only a small percentage of donated organs are available to address the vast need. For this reason, we are working to create manufactured organs to address the shortage of kidneys, hearts, lungs, and livers available for transplant. We believe an unlimited supply of tolerable, transplantable organs will eliminate the transplant waiting list and cure end-stage organ diseases for which transplant is not currently an option.
Who You Are
You’ll be a key driver of insight behind the decisions that shape United Therapeutics’ future. In this role, you’ll partner closely with budget managers and senior leaders to translate complex operational activity into clear financial narratives, forward‑looking forecasts, and actionable recommendations. You’ll build and refine models that support long‑term strategy, identify trends and risks early, and elevate how financial performance is analyzed and communicated across the organization. This position is ideal for someone who thrives on ownership, enjoys turning data into clarity, and wants their work to directly support therapies that make a real difference for patients
The Lead Analyst, Financial Planning & Analysis, plays a critical role in delivering high-quality financial analysis, modeling, and reporting to support data-driven decision-making across the organization. This professional serves as a subject-matter expert in FP&A processes and systems, partnering closely with finance leaders and cross-functional stakeholders to develop forecasts, identify trends, and drive continuous improvement. The Lead Analyst operates with a high degree of independence, providing analysis in a timely manner and translates complex financial data into clear, actionable insights.
For this role you will need
Minimum Requirements
Preferred Qualifications
Job Location
This position will be located in the RTP, NC office of United Therapeutics. Currently this job is a hybrid role requiring at least three days per week in the office. In office requirements could increase based on business needs.
At United Therapeutics, our mission and vision are one. We use our enthusiasm, creativity, and persistence to innovate for the unmet medical needs of our patients and to benefit our other stakeholders. We are bold and unconventional. We have fun, we do good.
Eligible employees may participate in the Company’s comprehensive benefits suite of programs, including medical / dental / vision / prescription coverage, employee wellness resources, savings plans (401k and ESPP), paid time off & paid parental leave benefits, disability benefits, and more. For additional information on Company benefits, please visit https://www.unither.com/careers/benefits-and-amenities
United Therapeutics Corporation is an Equal Opportunity Employer, including veterans and individuals with disabilities.

Founded to find a cure for a daughter’s rare disease, United Therapeutics is a biotechnology company transforming care for people with chronic and life-threatening conditions. Our purpose is to provide a brighter future for patients through the development of novel pharmaceutical therapies and technologies that expand the availability of transplantable organs. We are bold and unconventional. We have fun, we do good. We are also the first publicly-traded biotech or pharmaceutical company to take the form of a public benefit corporation.